11-12-13 4:15 PM EST | Email Article

Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of investors who purchased BioScrip, Inc. (“BioScrip” or the “Company”) (NasdaqGS:BIOS) common stock between August 8, 2011 and September 20, 2013.

For more information, click here: http://zlk.9nl.com/bioscrip-bios/.

The Complaint alleges that throughout the Class Period, defendants made materially false and misleading statements and/or omitted materially adverse facts about the Company’s business, operations and prospects. In particular, it is alleged that the Company violated the False Claims Act and other federal and state statutes by improperly distributing the Novartis Pharmaceuticals Corporation product Exjade through its specialty pharmacy operations.

On September 23, 2013, the Company acknowledged the receipt of a civil investigate demand issued by the US Attorney’s Office for the Southern District of New York and the receipt of a subpoena from the New York State Attorney General’s Medicaid Fraud Control Unit. Upon this news, shares of BioScrip fell more than 23 percent.

If you suffered a loss in BioScrip you have until November 29, 2013 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/bioscrip-bios/.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut, and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.

Add a Comment

News   More...

BioScrip, Inc. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against BioScrip, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of November 29, 2013 ()
BioScrip, Inc. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against BioScrip, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of November 29, 2013 -- BIOS (2013/10/21)
BioScrip, Inc. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against BioScrip, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of November 29, 2013 -- BIOS ()
BANKRATE, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Bankrate, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2013 (2013/12/2)
BANKRATE, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Bankrate, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2013 -- RATE (2013/11/22)
OvaScience, Inc. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Class Action against OvaScience, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of November 15, 2013 ()
OvaScience, Inc. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Class Action Against OvaScience, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of November 15, 2013 -- OVAS ()
OvaScience, Inc. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Class Action Against OvaScience, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of November 15, 2013 -- OVAS (2013/10/15)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Class Action Against OvaScience, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of November 15, 2013 -- OVAS (2013/10/7)
BIOLASE INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Class Action Against Biolase, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of October 22, 2013 -- BIOL (2013/10/14)
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Content Partners
Morningstar - - BioScrip, Inc. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against BioScrip, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of November 29, 2013
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Author |  Collection |  Interest |  Popularity

Previous: BioScrip, Inc. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against BioScrip, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of November 29, 2013  |  Next: BioScrip, Inc. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against BioScrip, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of November 29, 2013 -- BIOS